Literature DB >> 20960271

Endogenous estrogen levels are associated with endothelial function in males independently of lipid levels.

Katerina Saltiki1, George Papageorgiou, Paraskevi Voidonikola, Emily Mantzou, Konstantinos Xiromeritis, Christos Papamichael, Maria Alevizaki, Kimon Stamatelopoulos.   

Abstract

Estrogens and androgens may play an important role in vascular health in both sexes. The aim of this study was to examine the relation of endogenous sex hormone levels with early markers of atherosclerosis in a cohort of apparently healthy males. 124 males (age 46.25 ± 9.56) attending a preventive medicine program were examined for unrecognised features of the metabolic syndrome. Flow-mediated dilatation (FMD) and intima-media thickness (IMT) of the common carotid artery were evaluated. Obesity parameters were recorded; estradiol, testosterone, SHBG, free testosterone, insulin, as well as glucose and lipid levels were measured. FMD was positively correlated with estradiol (r = 0.201, P = 0.041) and negatively with total cholesterol (r = -0.205, P = 0.022), low density lipoproteins (r = -0.232, P = 0.009), and triglyceride levels (r = -0.179, P = 0.046). In multivariate analysis, the association of FMD with estrogen was independent of BMI and lipid levels. No significant association between FMD and testosterone levels was found. Subjects with an increased mean IMT (> 0.73 mm, i.e., > 3rd tertile) had lower levels of free (P = 0.021) and bioavailable (P = 0.016) testosterone. In multivariate logistic regression analysis, this association was no longer significant when age or cholesterol levels were considered. Endogenous estrogen levels are associated with FMD, independently of age and lipid levels, showing a protective effect in middle-age male subjects. Circulating androgens are associated, although not independently, with structural changes such as the IMT of carotid artery; this effect is possibly influenced by lipid levels and age.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20960271     DOI: 10.1007/s12020-010-9307-7

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  50 in total

1.  Orally and transdermally replaced estradiol improves endothelial function equally in middle-aged women after surgical menopause.

Authors:  Branka Zegura; Irena Keber; Miran Sebestjen; Elko Borko
Journal:  Am J Obstet Gynecol       Date:  2003-05       Impact factor: 8.661

2.  Increased carotid atherosclerosis in andropausal middle-aged men.

Authors:  Juuso Mäkinen; Mikko J Järvisalo; Pasi Pöllänen; Antti Perheentupa; Kerttu Irjala; Markku Koskenvuo; Juha Mäkinen; Ilpo Huhtaniemi; Olli T Raitakari
Journal:  J Am Coll Cardiol       Date:  2005-05-17       Impact factor: 24.094

3.  Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study.

Authors:  Kay-Tee Khaw; Mitch Dowsett; Elizabeth Folkerd; Sheila Bingham; Nicholas Wareham; Robert Luben; Ailsa Welch; Nicholas Day
Journal:  Circulation       Date:  2007-11-26       Impact factor: 29.690

4.  Endogenous sex hormones and cardiovascular disease incidence in men.

Authors:  Johan Arnlöv; Michael J Pencina; Shreyasee Amin; Byung-Ho Nam; Emelia J Benjamin; Joanne M Murabito; Thomas J Wang; Philip E Knapp; Ralph B D'Agostino; Shalendar Bhasin; Ramachandran S Vasan
Journal:  Ann Intern Med       Date:  2006-08-01       Impact factor: 25.391

5.  Acute administration of 17beta-oestradiol does not improve endothelium-dependent vasodilatation in young men.

Authors:  G New; S J Duffy; K L Berry; R W Harper; I T Meredith
Journal:  Clin Sci (Lond)       Date:  1999-08       Impact factor: 6.124

6.  Correlating androgen and estrogen steroid receptor expression with coronary calcification and atherosclerosis in men without known coronary artery disease.

Authors:  Peter Y Liu; Rose C Christian; Ming Ruan; Virginia M Miller; Lorraine A Fitzpatrick
Journal:  J Clin Endocrinol Metab       Date:  2004-11-09       Impact factor: 5.958

7.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.

Authors:  D S Celermajer; K E Sorensen; V M Gooch; D J Spiegelhalter; O I Miller; I D Sullivan; J K Lloyd; J E Deanfield
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

8.  The androgen receptor gene CAG polymorphism is associated with the severity of coronary artery disease in men.

Authors:  M Alevizaki; A T Cimponeriu; M Garofallaki; H L Sarika; C C Alevizaki; C Papamichael; G Philippou; E A Anastasiou; J P Lekakis; M Mavrikakis
Journal:  Clin Endocrinol (Oxf)       Date:  2003-12       Impact factor: 3.478

Review 9.  Androgens and cardiovascular disease.

Authors:  Peter Y Liu; Alison K Death; David J Handelsman
Journal:  Endocr Rev       Date:  2003-06       Impact factor: 19.871

10.  Endogenous sex hormones and progression of carotid atherosclerosis in elderly men.

Authors:  Majon Muller; Annewieke W van den Beld; Michiel L Bots; Diederick E Grobbee; Steven W J Lamberts; Yvonne T van der Schouw
Journal:  Circulation       Date:  2004-04-19       Impact factor: 29.690

View more
  8 in total

Review 1.  Testosterone and heart failure.

Authors:  Maurizio Volterrani; Giuseppe Rosano; Ferdinando Iellamo
Journal:  Endocrine       Date:  2012-06-24       Impact factor: 3.633

2.  Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes.

Authors:  Carmine Gazzaruso; Adriana Coppola; Tiziana Montalcini; Cinzia Valenti; Adriana Garzaniti; Gabriele Pelissero; Fabrizio Salvucci; Pietro Gallotti; Arturo Pujia; Colomba Falcone; Sebastiano B Solerte; Andrea Giustina
Journal:  Endocrine       Date:  2011-08-23       Impact factor: 3.633

3.  Relation between serum estradiol levels and mortality in postmenopausal female hemodialysis patients.

Authors:  Mehmet Tanrisev; Gulay Asci; Ozkan Gungor; Fatih Kircelli; Ebru Sevinc Ok; Mumtaz Yilmaz; Osman Z Sahin; Kezban Pinar Ozen; Gultekin Suleymanlar; Huseyin Toz; Ercan Ok
Journal:  Int Urol Nephrol       Date:  2012-04-18       Impact factor: 2.370

4.  Estrogen receptor inhibits mineralocorticoid receptor transcriptional regulatory function.

Authors:  Katelee Barrett Mueller; Qing Lu; Najwa N Mohammad; Victor Luu; Amy McCurley; Gordon H Williams; Gail K Adler; Richard H Karas; Iris Z Jaffe
Journal:  Endocrinology       Date:  2014-07-22       Impact factor: 4.736

5.  Impact of the association between elevated oestradiol and low testosterone levels on erectile dysfunction severity.

Authors:  Ahmed I El-Sakka
Journal:  Asian J Androl       Date:  2013-05-06       Impact factor: 3.285

6.  Determinants of testosterone levels in human male obesity.

Authors:  Marlies Bekaert; Yves Van Nieuwenhove; Patrick Calders; Claude A Cuvelier; Arsène-Hélène Batens; Jean-Marc Kaufman; D Margriet Ouwens; Johannes B Ruige
Journal:  Endocrine       Date:  2015-03-13       Impact factor: 3.633

7.  The impact of estradiol and 1,25(OH)2D3 on metabolic syndrome in middle-aged Taiwanese males.

Authors:  Kai-Hung Cheng; Shu-Pin Huang; Chun-Nung Huang; Yung-Chin Lee; Chih-Sheng Chu; Chu-Fen Chang; Wen-Ter Lai; Chia-Chu Liu
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

8.  Gender disparity in LDL-induced cardiovascular damage and the protective role of estrogens against electronegative LDL.

Authors:  An-Sheng Lee; Wei-Yu Chen; Hua-Chen Chan; Jing-Fang Hsu; Ming-Yi Shen; Chia-Ming Chang; Henry Bair; Ming-Jai Su; Kuan-Cheng Chang; Chu-Huang Chen
Journal:  Cardiovasc Diabetol       Date:  2014-03-25       Impact factor: 9.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.